Nokia supports diabetes app

  • 9 April 2010

An application has been launched to provide access to the MyGlucoHealth diabetes management system from Nokia mobile phones worldwide.

The application is the result of a partnership between Nokia and Entra Health, which developed the MyGlucoHealth wireless meter and portal.

It allows allows Nokia users to upload and manage blood glucose readings through the portal. They can review and evaluate results on their handset, and also enter weight, exercise and nutritional information.

The application can also notify family, doctors or caregivers when results exceed personally established threshold limits. And users can send and receive secure messages from their physician.

John Hendel, chairman of Entra Health Systems, said: “Distributing the MyGlucoHealth diabetes app via Ovi Store for Nokia users will strengthen our ability to provide more effective mHealth offerings worldwide.

“We believe that MyGlucoHealth together with Nokia handsets offers a unique and far-reaching solution for connecting patients with clinicians, family and caregivers.”

The app has already been test marketed. Within four weeks, it was downloaded 40,000 times by Nokia users in 130 countries.

The MyGlucoHealth Mobile App is available for free from the Ovi Store: www.store.ovi.com.

Links: Entra Health Systems

Nokia

Subscribe To Our Newsletters

Subscribe to our newsletter

Subscribe To Our Newsletter

Related News

North East and Yorkshire trusts adopt tech for faster scan results

North East and Yorkshire trusts adopt tech for faster scan results

NHS England is expanding the rollout of Hexarad to help patients in the North East and South Yorkshire receive hospital scan results faster.
Digital Health’s monthly roundup of contracts and go lives

Digital Health’s monthly roundup of contracts and go lives

Our latest roundup features Powys Teaching Health Board rolling out an electronic prescribing and medicines administration (ePMA) system.
NHS AI blood test could reduce invasive cancer exams for women

NHS AI blood test could reduce invasive cancer exams for women

Thousands of women could avoid invasive diagnostic procedures for suspected womb cancer under an NHS trial of an AI blood test.